Enteric Neuromuscular Pathology Update

Gastroenterology Clinics of North America

Volumn 40, Issue 4, 2011, Pages 695-713

  Knowles, Charles H ^a   Martin, Joanne E ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Constipation; Enteric myopathy; Enteric neuropathy; Gastrointestinal neuromuscular disease; Gastroparesis; Intestinal pseudo obstruction

Indexed keywords

CLINICAL FEATURE; CONSTIPATION; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; ESOPHAGUS ACHALASIA; GASTROINTESTINAL DISEASE; HIRSCHSPRUNG DISEASE; HISTOPATHOLOGY; HUMAN; INTESTINAL DYSMOTILITY; INTESTINE PSEUDOOBSTRUCTION; MEGACOLON; MITOCHONDRIAL ENCEPHALOMYOPATHY; NEUROMUSCULAR DISEASE; PARANEOPLASTIC SYNDROME; PARKINSON DISEASE; PROGNOSIS; REVIEW; STANDARDIZATION; STOMACH PARESIS; TISSUE PREPARATION; PATHOLOGY;

GASTROINTESTINAL DISEASES; HUMANS; NEUROMUSCULAR DISEASES;

EID: 81455132589     PISSN: 08898553     EISSN: 15581942     Source Type: Journal    
DOI: 10.1016/j.gtc.2011.09.007     Document Type: Review

References (83)

1. Knowles C.H., De Giorgio R., Kapur R.P., et al. The London Classification of gastrointestinal neuromuscular pathology: report on behalf of the Gastro 2009 International Working Group. Gut 2010, 59(7):882-887.
2. Knowles C.H., De Giorgio R., Kapur R.P., et al. Gastrointestinal neuromuscular pathology: guidelines for histological techniques and reporting on behalf of the Gastro 2009 International Working Group. Acta Neuropathol 2009, 118(2):271-301.
3. Knowles C.H., Veress B., Kapur R.P., et al. Quantitation of cellular components of the enteric nervous system in the normal human gastrointestinal tract-report on behalf of the Gastro 2009 International Working Group. Neurogastroenterol Motil 2011, 23(2):115-124.
4. Knowles C.H., Veress B., Tornblom H., et al. Safety and diagnostic yield of laparoscopically assisted full-thickness bowel biospy. Neurogastroenterol Motil 2008, 20(7):774-779.
5. Lindberg G., Tornblom H., Iwarzon M., et al. Full-thickness biopsy findings in chronic intestinal pseudo-obstruction and enteric dysmotility. Gut 2009, 58(8):1084-1090.
6. Fitzgibbons P.L., Chandrasoma P.T. Familial visceral myopathy. Evidence of diffuse involvement of intestinal smooth muscle. Am J Surg Pathol 1987, 11(11):846-854.
7. Martin J.E., Hester T.W., Aslam H., et al. Discordant practice and limited histopathological assessment in gastrointestinal neuromuscular disease. Gut 2009, 58(12):1703-1705.
8. Swaminathan M., Kapur R.P. Counting myenteric ganglion cells in histologic sections: an empirical approach. Hum Pathol 2010, 41(8):1097-1108.
9. Scott S.M., Knowles C.H., Wang D., et al. The nocturnal jejunal migrating motor complex: defining normal ranges by study of 51 healthy adult volunteers and meta-analysis. Neurogastroenterol Motil 2006, 18(10):927-935.
10. De Giorgio R., Barbara G., Stanghellini V., et al. Clinical and morphofunctional features of idiopathic myenteric ganglionitis underlying severe intestinal motor dysfunction: a study of three cases. Am J Gastroenterol 2002, 97(9):2454-2459.
11. Pasha S.F., Lunsford T.N., Lennon V.A. Autoimmune gastrointestinal dysmotility treated successfully with pyridostigmine. Gastroenterology 2006, 131(5):1592-1596.
12. Hubball A., Martin J.E., Lang B., et al. The role of humoral autoimmunity in gastrointestinal neuromuscular diseases. Prog Neurobiol 2009, 87(1):10-20.
13. Heneyke S., Smith V.V., Spitz L., et al. Chronic intestinal pseudo-obstruction: treatment and long term follow up of 44 patients. Arch Dis Child 1999, 81(1):21-27.
14. Wingate D.L. "Functional" should not be shorthand for "I don't know" in dyspepsia. BMJ 2002, 324(7333):364.
15. Csendes A., Smok G., Braghetto I., et al. Histological studies of Auerbach's plexuses of the oesophagus, stomach, jejunum, and colon in patients with achalasia of the oesophagus: correlation with gastric acid secretion, presence of parietal cells and gastric emptying of solids. Gut 1992, 33(2):150-154.
16. Goldblum J.R., Rice T.W., Richter J.E. Histopathologic features in esophagomyotomy specimens from patients with achalasia. Gastroenterology 1996, 111(3):648-654.
17. Zarate N., Wang X.Y., Tougas G., et al. Intramuscular interstitial cells of Cajal associated with mast cells survive nitrergic nerves in achalasia. Neurogastroenterol Motil 2006, 18(7):556-568.
18. Gockel I., Bohl J.R., Eckardt V.F., et al. Reduction of interstitial cells of Cajal (ICC) associated with neuronal nitric oxide synthase (n-NOS) in patients with achalasia. Am J Gastroenterol 2008, 103(4):856-864.
19. Clark S.B., Rice T.W., Tubbs R.R., et al. The nature of the myenteric infiltrate in achalasia: an immunohistochemical analysis. Am J Surg Pathol 2000, 24(8):1153-1158.
20. Ejskjaer N.T., Bradley J.L., Buxton-Thomas M.S., et al. Novel surgical treatment and gastric pathology in diabetic gastroparesis. Diabet Med 1999, 16(6):488-495.
21. Zarate N., Mearin F., Wang X.Y., et al. Severe idiopathic gastroparesis due to neuronal and interstitial cells of Cajal degeneration: pathological findings and management. Gut 2003, 52(7):966-970.
22. Grover M., Farrugia G., Lurken M.S., et al. Cellular changes in diabetic and idiopathic gastroparesis. Gastroenterology 2011, 140(5):1575-1585. e1578.
23. Knowles C.H., Silk D.B., Darzi A., et al. Deranged smooth muscle alpha-actin as a biomarker of intestinal pseudo-obstruction: a controlled multinational case series. Gut 2004, 53(11):1583-1589.
24. Rudolph C.D., Hyman P.E., Altschuler S.M., et al. Diagnosis and treatment of chronic intestinal pseudo-obstruction in children: report of consensus workshop. J Pediatr Gastroenterol Nutr 1997, 24(1):102-112.
25. Schuffler M.D., Lowe M.C., Bill A.H. Studies of idiopathic intestinal pseudoobstruction. I. Hereditary hollow visceral myopathy: clinical and pathological studies. Gastroenterology 1977, 73(2):327-338.
26. Smith V.V., Milla P.J. Histological phenotypes of enteric smooth muscle disease causing functional intestinal obstruction in childhood. Histopathology 1997, 31(2):112-122.
27. Kapur R.P., Robertson S.P., Hannibal M.C., et al. Diffuse abnormal layering of small intestinal smooth muscle is present in patients with FLNA mutations and X-linked intestinal pseudo-obstruction. Am J Surg Pathol 2010, 34(10):1528-1543.
28. Rudin C., Jenny P., Ohnacker H., et al. Absence of the enteric nervous system in the newborn: presentation of three patients and review of the literature. J Pediatr Surg 1986, 21(4):313-318.
29. Navarro J., Sonsino E., Boige N., et al. Visceral neuropathies responsible for chronic intestinal pseudo-obstruction syndrome in pediatric practice: analysis of 26 cases. J Pediatr Gastroenterol Nutr 1990, 11(2):179-195.
30. Pingault V., Girard M., Bondurand N., et al. SOX10 mutations in chronic intestinal pseudo-obstruction suggest a complex physiopathological mechanism. Hum Genet 2002, 111(2):198-206.
31. Deglincerti A., De Giorgio R., Cefle K., et al. A novel locus for syndromic chronic idiopathic intestinal pseudo-obstruction maps to chromosome 8q23-q24. Eur J Hum Genet 2007, 15(8):889-897.
32. Auricchio A., Brancolini V., Casari G., et al. The locus for a novel syndromic form of neuronal intestinal pseudoobstruction maps to Xq28. Am J Hum Genet 1996, 58(4):743-748.
33. Wingate D., Hongo M., Kellow J., et al. Disorders of gastrointestinal motility: towards a new classification. J Gastroenterol Hepatol 2002, 17(Suppl):S1-S14.
34. Lindberg G., Iwarzon M., Tornblom H. Clinical features and long-term survival in chronic intestinal pseudo-obstruction and enteric dysmotility. Scand J Gastroenterol 2009, 44(6):692-699.
35. Schuffler M.D., Jonak Z. Chronic idiopathic intestinal pseudo-obstruction caused by a degenerative disorder of the myenteric plexus: the use of Smith's method to define the neuropathology. Gastroenterology 1982, 82(3):476-486.
36. Scholz J., Woolf C.J. The neuropathic pain triad: neurons, immune cells and glia. Nat Neurosci 2007, 10(11):1361-1368.
37. Olesen A.E., Staahl C., Arendt-Nielsen L., et al. Different effects of morphine and oxycodone in experimentally evoked hyperalgesia: a human translational study. Br J Clin Pharmacol 2010, 70(2):189-200.
38. King S.K., Sutcliffe J.R., Hutson J.M. Laparoscopic seromuscular colonic biopsies: a surgeon's experience. J Pediatr Surg 2005, 40(2):381-384.
39. Hutson J.M., Chow C.W., Borg J. Intractable constipation with a decrease in substance P-immunoreactive fibres: is it a variant of intestinal neuronal dysplasia?. J Pediatr Surg 1996, 31(4):580-583.
40. Veress B., Nyberg B., Tornblom H., et al. Intestinal lymphocytic epithelioganglionitis: a unique combination of inflammation in bowel dysmotility: a histopathological and immunohistochemical analysis of 28 cases. Histopathology 2009, 54(5):539-549.
41. Knowles C.H., Farrugia G. Gastrointestinal neuromuscular pathology in chronic constipation. Best Pract Res Clin Gastroenterol 2011, 25(1):43-57.
42. Smith B., Grace R.H., Todd I.P. Organic constipation in adults. Br J Surg 1977, 64(5):313-314.
43. Krishnamurthy S., Schuffler M.D., Rohrmann C.A., et al. Severe idiopathic constipation is associated with a distinctive abnormality of the colonic myenteric plexus. Gastroenterology 1985, 88(1 Pt 1):26-34.
44. Porter A.J., Wattchow D.A., Hunter A., et al. Abnormalities of nerve fibers in the circular muscle of patients with slow transit constipation. Int J Colorectal Dis 1998, 13(5-6):208-216.
45. Wattchow D., Brookes S., Murphy E., et al. Regional variation in the neurochemical coding of the myenteric plexus of the human colon and changes in patients with slow transit constipation. Neurogastroenterol Motil 2008, 20(12):1298-1305.
46. Burleigh D.E. Evidence for a functional cholinergic deficit in human colonic tissue resected for constipation. J Pharm Pharmacol 1988, 40(1):55-57.
47. Mitolo-Chieppa D., Mansi G., Rinaldi R., et al. Cholinergic stimulation and nonadrenergic, noncholinergic relaxation of human colonic circular muscle in idiopathic chronic constipation. Dig Dis Sci 1998, 43(12):2719-2726.
48. Camilleri M., Kerstens R., Rykx A., et al. A placebo-controlled trial of prucalopride for severe chronic constipation. N Engl J Med 2008, 358(22):2344-2354.
49. Scharli A.F., Meier-Ruge W. Localized and disseminated forms of neuronal intestinal dysplasia mimicking Hirschsprung's disease. J Pediatr Surg 1981, 16(2):164-170.
50. Koletzko S., Jesch I., Faus-Kebetaler T., et al. Rectal biopsy for diagnosis of intestinal neuronal dysplasia in children: a prospective multicentre study on interobserver variation and clinical outcome. Gut 1999, 44(6):853-861.
51. He C.L., Burgart L., Wang L., et al. Decreased interstitial cell of cajal volume in patients with slow-transit constipation. Gastroenterology 2000, 118(1):14-21.
52. Lyford G.L., He C.L., Soffer E., et al. Pan-colonic decrease in interstitial cells of Cajal in patients with slow transit constipation. Gut 2002, 51(4):496-501.
53. Wedel T., Spiegler J., Soellner S., et al. Enteric nerves and interstitial cells of Cajal are altered in patients with slow-transit constipation and megacolon. Gastroenterology 2002, 123(5):1459-1467.
54. Garrity M.M., Gibbons S.J., Smyrk T.C., et al. Diagnostic challenges of motility disorders: optimal detection of CD117+ interstitial cells of Cajal. Histopathology 2009, 54(3):286-294.
55. Der T., Bercik P., Donnelly G., et al. Interstitial cells of cajal and inflammation-induced motor dysfunction in the mouse small intestine. Gastroenterology 2000, 119(6):1590-1599.
56. Chang I.Y., Glasgow N.J., Takayama I., et al. Loss of interstitial cells of Cajal and development of electrical dysfunction in murine small bowel obstruction. J Physiol (Lond) 2001, 536(2):555-568.
57. Farrugia G. Interstitial cells of Cajal in health and disease. Neurogastroent Motil 2008, 20:54-63.
58. DiMauro S., Schon E.A. Mitochondrial respiratory-chain diseases. N Engl J Med 2003, 348(26):2656-2668.
59. Nishino I., Spinazzola A., Papadimitriou A., et al. Mitochondrial neurogastrointestinal encephalomyopathy: an autosomal recessive disorder due to thymidine phosphorylase mutations. Ann Neurol 2000, 47(6):792-800.
60. Giordano C., Sebastiani M., De Giorgio R., et al. Gastrointestinal dysmotility in mitochondrial neurogastrointestinal encephalomyopathy is caused by mitochondrial DNA depletion. Am J Pathol 2008, 173(4):1120-1128.
61. Perez-Atayde A.R., Fox V., Teitelbaum J.E., et al. Mitochondrial neurogastrointestinal encephalomyopathy: diagnosis by rectal biopsy. Am J Surg Pathol 1998, 22(9):1141-1147.
62. Muehlenberg K., Fiedler A., Schaumann I., et al. [Intestinal pseudoobstructions and gastric necrosis in mitochondrial myopathy]. Dtsch Med Wochenschr 2002, 127(12):611-615.
63. Chinn J.S., Schuffler M.D. Paraneoplastic visceral neuropathy as a cause of severe gastrointestinal motor dysfunction. Gastroenterology 1988, 95(5):1279-1286.
64. Lucchinetti C.F., Kimmel D.W., Lennon V.A. Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies. Neurology 1998, 50(3):652-657.
65. Vernino S., Adamski J., Kryzer T.J., et al. Neuronal nicotinic ACh receptor antibody in subacute autonomic neuropathy and cancer-related syndromes. Neurology 1998, 50(6):1806-1813.
66. Lee H.R., Lennon V.A., Camilleri M., et al. Paraneoplastic gastrointestinal motor dysfunction: clinical and laboratory characteristics. Am J Gastroenterol 2001, 96(2):373-379.
67. Schuffler M.D., Baird H.W., Fleming C.R., et al. Intestinal pseudo-obstruction as the presenting manifestation of small-cell carcinoma of the lung. A paraneoplastic neuropathy of the gastrointestinal tract. Ann Intern Med 1983, 98(2):129-134.
68. Altermatt H.J., Rodriguez M., Scheithauer B.W., et al. Paraneoplastic anti-Purkinje and type I anti-neuronal nuclear autoantibodies bind selectively to central, peripheral, and autonomic nervous system cells. Lab Invest 1991, 65(4):412-420.
69. Lennon V.A., Sas D.F., Busk M.F., et al. Enteric neuronal autoantibodies in pseudoobstruction with small-cell lung carcinoma. Gastroenterology 1991, 100(1):137-142.
70. Vernino S., Low P.A., Fealey R.D., et al. Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N Engl J Med 2000, 343(12):847-855.
71. Qualman S.J., Haupt H.M., Yang P., Hamilton S.R. Esophageal Lewy bodies associated with ganglion cell loss in achalasia. Similarity to Parkinson's disease. Gastroenterology 1984, 87(4):848-856.
72. Braak H., Braak E. Pathoanatomy of Parkinson's disease. J Neurol 2000, 247(Suppl 2):II3-II10.
73. Lebouvier T., Neunlist M., Bruley des Varannes S., et al. Colonic biopsies to assess the neuropathology of Parkinson's disease and its relationship with symptoms. PLoS One 2010, 5(9):e12728.
74. Lebouvier T., Chaumette T., Damier P., et al. Pathological lesions in colonic biopsies during Parkinson's disease. Gut 2008, 57(12):1741-1743.
75. Nakahara M., Isozaki K., Hirota S., et al. Deficiency of KIT-positive cells in the colon of patients with diabetes mellitus. J Gastroenterol Hepatol 2002, 17(6):666-670.
76. He C.L., Soffer E.E., Ferris C.D., et al. Loss of interstitial cells of Cajal and inhibitory innervation in insulin-dependent diabetes. Gastroenterology 2001, 121(2):427-434.
77. Wang X.Y., Huizinga J.D., Diamond J., et al. Loss of intramuscular and submuscular interstitial cells of Cajal and associated enteric nerves is related to decreased gastric emptying in streptozotocin-induced diabetes. Neurogastroenterol Motil 2009, 21(10). 1095-e92.
78. Rose S., Young M.A., Reynolds J.C. Gastrointestinal manifestations of scleroderma. Gastroenterol Clin North Am 1998, 27(3):563-594.
79. Schuffler M.D., Beegle R.G. Progressive systemic sclerosis of the gastrointestinal tract and hereditary hollow visceral myopathy: two distinguishable disorders of intestinal smooth muscle. Gastroenterology 1979, 77(4 Pt 1):664-671.
80. Roberts C.G., Hummers L.K., Ravich W.J., et al. A case-control study of the pathology of oesophageal disease in systemic sclerosis (scleroderma). Gut 2006, 55(12):1697-1703.
81. Hietarinta M., Ilonen J., Lassila O., et al. Association of HLA antigens with anti-Scl-70-antibodies and clinical manifestations of systemic sclerosis (scleroderma). Br J Rheumatol 1994, 33(4):323-326.
82. Gilchrist F.C., Bunn C., Foley P.J., et al. Class II HLA associations with autoantibodies in scleroderma: a highly significant role for HLA-DP. Genes Immun 2001, 2(2):76-81.
83. Goldblatt F., Gordon T.P., Waterman S.A. Antibody-mediated gastrointestinal dysmotility in scleroderma. Gastroenterology 2002, 123(4):1144-1150.